Literature DB >> 7556645

Glycogen synthase kinase 3 phosphorylates recombinant human tau protein at serine-262 in the presence of heparin (or tubulin).

F J Moreno1, M Medina, M Pérez, E Montejo de Garcini, J Avila.   

Abstract

Tau protein, the major component of the aberrant structures termed paired helical filaments (PHFs) present in the brain of Alzheimer's disease patients, is pathologically phosphorylated in sites in and around the tubulin-binding sites. A single protein kinase, glycogen synthase kinase 3 (GSK 3), is able to phosphorylate tau at the flanking regions and, additionally, at the tubulin-binding motifs if heparin or tubulin is present. Serines-262 and -324 have been found to be modified at the tubulin-binding region of tau protein by GSK 3 in the presence of heparin or tubulin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7556645     DOI: 10.1016/0014-5793(95)00934-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

Review 1.  Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration.

Authors:  M L Billingsley; R L Kincaid
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

2.  Neurotoxic dopamine quinone facilitates the assembly of tau into fibrillar polymers.

Authors:  Ismael Santa-María; Félix Hernández; Mark A Smith; George Perry; Jesús Avila; Francisco J Moreno
Journal:  Mol Cell Biochem       Date:  2005-10       Impact factor: 3.396

3.  Regulation of phosphorylation of tau by cyclin-dependent kinase 5 and glycogen synthase kinase-3 at substrate level.

Authors:  Amitabha Sengupta; Michal Novak; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  FEBS Lett       Date:  2006-10-05       Impact factor: 4.124

4.  Phosphorylation of tau by glycogen synthase kinase 3beta affects the ability of tau to promote microtubule self-assembly.

Authors:  M A Utton; A Vandecandelaere; U Wagner; C H Reynolds; G M Gibb; C C Miller; P M Bayley; B H Anderton
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

5.  Protein kinase MARK/PAR-1 is required for neurite outgrowth and establishment of neuronal polarity.

Authors:  Jacek Biernat; Yong-Zhong Wu; Thomas Timm; Qingyi Zheng-Fischhöfer; Eckhard Mandelkow; Laurent Meijer; Eva-Maria Mandelkow
Journal:  Mol Biol Cell       Date:  2002-11       Impact factor: 4.138

6.  Caloric restriction mimetic 2-deoxyglucose maintains cytoarchitecture and reduces tau phosphorylation in primary culture of mouse hippocampal pyramidal neurons.

Authors:  M S Bele; K A Gajare; A A Deshmukh
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-02-13       Impact factor: 2.416

7.  Specific Peptide from the Novel W-Tau Isoform Inhibits Tau and Amyloid β Peptide Aggregation In Vitro.

Authors:  Raquel Cuadros; Mar Pérez; Daniel Ruiz-Gabarre; Félix Hernández; Vega García-Escudero; Jesús Avila
Journal:  ACS Chem Neurosci       Date:  2022-06-13       Impact factor: 5.780

8.  Ferritin is associated with the aberrant tau filaments present in progressive supranuclear palsy.

Authors:  M Pérez; J M Valpuesta; E M de Garcini; C Quintana; M Arrasate; J L López Carrascosa; A Rábano; J García de Yébenes; J Avila
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

9.  GSK-3 in Neurodegenerative Diseases.

Authors:  Peng Lei; Scott Ayton; Ashley I Bush; Paul A Adlard
Journal:  Int J Alzheimers Dis       Date:  2011-05-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.